RAFFA WEALTH MANAGEMENT, LLC’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
ECSS
EB
CPC
AIM
AAMU
AAIS
SIC
RAFFA WEALTH MANAGEMENT, LLC's DGX Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC reduced its Quest Diagnostics (DGX) stake by 86% in Q2 2026, selling an estimated $1.18K and leaving 1 share worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #1257.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in DGX in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.11K in Q4 2021. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 1 share of Quest Diagnostics worth $212 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
- Quest Diagnostics made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1257 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Quest Diagnostics in Q1 2018 and has held it in 33 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Quest Diagnostics position peaked at $3.11K in Q4 2021.
- 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.